# Why do <scp>SGLT2</scp> inhibitors reduce heart failure hospitalization? <scp>A</scp> differential volume regulation hypothesis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/why-do-scp-sglt2-scp-inhibitors-reduce-heart-failure-hospitalization-scp-a-scp/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Karen Melissa Hallow,Gabriel Helmlinger,Peter J. Greasley,John J.V. McMurray,David W. Boulton |
| Citations | 487 |
| DOI | 10.1111/dom.13126 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.13126 |
| OpenAlex ID | https://openalex.org/W2763866789 |
| PMID | 29024278 |
| Type | article |
| Year | 2017 |

## Paper authors

- [David W. Boulton](https://scholariq.org/researchers/david-w-boulton/)

## Paper journal

- [Diabetes Obesity and Metabolism](https://scholariq.org/journals/diabetes-obesity-and-metabolism/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.